Segment Wealth Management LLC Sells 45 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Segment Wealth Management LLC lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,052 shares of the medical equipment provider’s stock after selling 45 shares during the quarter. Segment Wealth Management LLC’s holdings in Intuitive Surgical were worth $2,637,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. State Street Corp increased its stake in Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after acquiring an additional 210,363 shares during the period. FMR LLC grew its holdings in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Intuitive Surgical by 1.9% in the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after purchasing an additional 143,440 shares during the period. Fisher Asset Management LLC raised its stake in Intuitive Surgical by 1.8% in the third quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after purchasing an additional 86,208 shares in the last quarter. Finally, Baillie Gifford & Co. lifted its position in Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after purchasing an additional 24,183 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $592.64 on Tuesday. The firm has a market cap of $211.09 billion, a PE ratio of 95.28, a P/E/G ratio of 5.04 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $362.14 and a 1 year high of $597.68. The stock has a fifty day moving average price of $540.66 and a 200-day moving average price of $499.64.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 22,903 shares of the company’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the transaction, the insider now directly owns 8,757 shares in the company, valued at $4,597,425. This represents a 72.34 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 43,509 shares of company stock valued at $22,602,212 over the last three months. 0.80% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms have commented on ISRG. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Morgan Stanley upgraded Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their target price for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Citigroup lifted their price target on Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Finally, The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $554.17.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.